<?xml version="1.0" encoding="UTF-8"?>
<fig id="f0010">
 <label>Fig. 2</label>
 <caption>
  <p>Virtual screening and docking of FDA drugs with COVID-19 Mpro. A) The top 40 compounds docked into the Mpro binding site. B) The docking site of ribavirin C) The ligand interactions of ribavirin with Mpro D) The site of docking of telbivudine E) The ligand interactions of telbivudine with Mpro. Hydrogen bonds are shown in purple arrows, hydrophobic interactions in grey circles. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</p>
 </caption>
 <alt-text id="al0010">Fig. 2</alt-text>
 <graphic xlink:href="gr2_lrg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
